Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Herborium | OTC Markets | Healthcare | Biotechnology & Medical Research | $1.09M | 0x | $0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Isodiol Intl | OTC Markets | Healthcare | Pharmaceuticals | $12.85K | 0x | $0.00010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Zhuding | OTC Markets | Industrials | Professional & Commercial Services | $1.94M | -0x | $0 | 14.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DeFi Tech | OTC Markets | Financial | Banking Services | $581.36M | 12.3x | 0.06 | $2 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acura Pharma | OTC Markets | Healthcare | Biotechnology & Medical Research | $318.48K | -0.1x | $0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ast Spacemobile | NASDAQ | Technology | Telecommunications Services | $4.69B | -22.9x | 0.52 | $29.83 | 11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Fastbase | OTC Markets | Technology | Software & IT Services | $9.76M | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Itokk | OTC Markets | Financial | Investment Holding Companies | $353.44K | $0.0007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ADMA Biologics Inc | NASDAQ | Healthcare | Pharmaceuticals | $4.22B | 119.2x | 0.68 | $18.09 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
LianBio ADR | OTC Markets | Healthcare | Biotechnology & Medical Research | $38.61M | -5.1x | -0.02 | $0.36 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AKA Brands Holding | NYSE | Consumer Cyclicals | Specialty Retailers | $266.57M | -1.8x | -0.06 | $25.28 | -17.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -20.9% Downside | Upgrade to Pro+ | |
South Beach Spirits | OTC Markets | Real Estate | Real Estate Operations | $2.47M | -1.1x | $0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lendingtree | NASDAQ | Financial | Banking Services | $764.14M | -6x | -0.3 | $57.27 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
FTAI Aviation | NASDAQ | Financial | Banking Services | $12.80B | -233.1x | 1.3 | $125.23 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Casi Pharma | NASDAQ | Healthcare | Pharmaceuticals | $107.90M | -3.5x | -0.12 | $7.17 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.3% Downside | Upgrade to Pro+ | |
Red Cat Holdings | NASDAQ | Industrials | Aerospace & Defense | $233.82M | -7.5x | -0.47 | $3.11 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.7% Upside | Upgrade to Pro+ | |
Giant Motorsports | OTC Markets | Consumer Cyclicals | Specialty Retailers | $8.02M | -75x | $0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CervoMed | NASDAQ | Healthcare | Biotechnology & Medical Research | $144.52M | -21.7x | $17.51 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Identa | OTC Markets | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | $2.25M | 3.2x | $0.56 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Yuenglings Ice Cream | OTC Markets | Technology | Software & IT Services | $2.41M | -2.5x | $0.004 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vitalhub | OTC Markets | Healthcare | Healthcare Equipment & Supplies | $325.29M | 83.1x | 0.11 | $6.38 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aquestive Therapeutics | NASDAQ | Healthcare | Pharmaceuticals | $440.73M | -13.7x | -1.17 | $4.84 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Entera Bio | NASDAQ | Healthcare | Biotechnology & Medical Research | $72.29M | -7.4x | -0.28 | $1.99 | 10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C4 | NASDAQ | Healthcare | Biotechnology & Medical Research | $446.54M | -3.4x | -0.11 | $6.44 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Praxis Precision | NASDAQ | Healthcare | Biotechnology & Medical Research | $1.06B | -6.2x | -0.11 | $59.88 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mentor Capital, Inc. | OTC Markets | Financial | Investment Banking & Investment Services | $2.21M | 0.7x | -0 | $0.09 | 27.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clover Health Investments | NASDAQ | Healthcare | Healthcare Providers & Services | $1.49B | -11.5x | -0.23 | $2.99 | 7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.1% Downside | Upgrade to Pro+ | |
Idaho Strategic Resources | NYSE | Basic Materials | Metals & Mining | $182.98M | 26.5x | 0.06 | $14.12 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Power Nickel | OTC Markets | Basic Materials | Metals & Mining | $92.87M | -6.4x | 0.15 | $0.48 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ESSA Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | $303.93M | -11.3x | 18.17 | $6.85 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |